{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:20:06Z","timestamp":1792700406328,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T00:00:00Z","timestamp":1462233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T00:00:00Z","timestamp":1462233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P50 DA009253"],"award-info":[{"award-number":["P50 DA009253"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00213-016-4308-8","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T23:58:03Z","timestamp":1462233483000},"page":"2571-2580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study"],"prefix":"10.1007","volume":"233","author":[{"given":"Josh D.","family":"Woolley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Arcuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Stauffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fulford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean S.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Batki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Vinogradov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,3]]},"reference":[{"key":"4308_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/archpsyc.1976.01770030067010","volume":"33","author":"TF Babor","year":"1976","unstructured":"Babor TF, Meyer RE, Mirin SM, Mcnamee HB, Davies M (1976) Behavioral and social effects of heroin self-administration and withdrawal. Arch Gen Psychiatry 33:363\u2013367","journal-title":"Arch Gen Psychiatry"},{"key":"4308_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/1469-7610.00715","volume":"42","author":"S Baron\u2010Cohen","year":"2001","unstructured":"Baron\u2010Cohen S, Wheelwright S, Hill J, Raste Y, Plumb I (2001) The \u201cReading the Mind in the Eyes\u201d test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. J Child Psychol Psychiatry 42:241\u2013251","journal-title":"J Child Psychol Psychiatry"},{"key":"4308_CR3","doi-asserted-by":"crossref","unstructured":"Bartz JA, Zaki J, Bolger N, Ochsner KN (2011) Social effects of oxytocin in humans: context and person matter. Trends Cogn Sci 15(7):301\u2013319","DOI":"10.1016\/j.tics.2011.05.002"},{"key":"4308_CR4","unstructured":"Black Tar Heroin: The Dark End of the Street (1999) Directed by OKAZAKI, S. United States: Farallon Films"},{"key":"4308_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.2044-8341.1974.tb02285.x","volume":"47","author":"A Bond","year":"1974","unstructured":"Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211\u2013218","journal-title":"Br J Med Psychol"},{"issue":"3","key":"4308_CR6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0893-133X(01)00371-2","volume":"26","author":"KR Bonson","year":"2002","unstructured":"Bonson KR, Grant SJ, Contoreggi CS, Links JM, Metcalfe J, Weyl HL, Kurian V, Ernst M, London ED (2002) Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 26(3):376\u201386","journal-title":"Neuropsychopharmacology"},{"key":"4308_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1600-0447.2009.01414.x","volume":"120","author":"E Bora","year":"2009","unstructured":"Bora E, Y\u00fccel M, Pantelis C (2009) Theory of mind impairment: a distinct trait-marker for schizophrenia spectrum disorders and bipolar disorder? Acta Psychiatr Scand 120:253\u2013264","journal-title":"Acta Psychiatr Scand"},{"key":"4308_CR8","doi-asserted-by":"crossref","unstructured":"Carson DS, Guastella AJ, Taylor ER, Mcgregor IS (2013) A brief history of oxytocin and its role in modulating psychostimulant effects. J Psychopharmacol 27(3):231\u2013247","DOI":"10.1177\/0269881112473788"},{"key":"4308_CR9","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1523\/JNEUROSCI.22-09-03321.2002","volume":"22","author":"TJ De Vries","year":"2002","unstructured":"De Vries TJ, Shippenberg TS (2002) Neural systems underlying opiate addiction. J Neurosci 22:3321\u20133325","journal-title":"J Neurosci"},{"key":"4308_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.biopsych.2006.07.015","volume":"61","author":"G Domes","year":"2007","unstructured":"Domes G, Heinrichs M, Michel A, Berger C, Herpertz SC (2007) Oxytocin improves \u201cmind-reading\u201d in humans. Biol Psychiatry 61:731\u2013733","journal-title":"Biol Psychiatry"},{"key":"4308_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1037\/0022-006X.68.1.134","volume":"68","author":"W Fals-Stewart","year":"2000","unstructured":"Fals-Stewart W, O\u2019Farrell TJ, Freitas TT, Mcfarlin SK, Rutigliano P (2000) The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 68:134","journal-title":"J Consult Clin Psychol"},{"key":"4308_CR12","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.biopsych.2010.04.039","volume":"68","author":"D Feifel","year":"2010","unstructured":"Feifel D, Macdonald K, Nguyen A, Cobb P, Warlan H, Galangue B, Minassian A, Becker O, Cooper J, Perry W (2010) Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry 68:678\u2013680","journal-title":"Biol Psychiatry"},{"key":"4308_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.dcn.2011.07.007","volume":"1","author":"I Gordon","year":"2011","unstructured":"Gordon I, Martin C, Feldman R, Leckman JF (2011) Oxytocin and social motivation. Dev Cogn Neurosci 1:471\u2013493","journal-title":"Dev Cogn Neurosci"},{"key":"4308_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1192\/bjp.154.3.348","volume":"154","author":"M Gossop","year":"1989","unstructured":"Gossop M, Green L, Phillips G, Bradley B (1989) Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study. Br J Psychiatry 154:348\u2013353","journal-title":"Br J Psychiatry"},{"key":"4308_CR15","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1046\/j.1360-0443.2002.00227.x","volume":"97","author":"M Gossop","year":"2002","unstructured":"Gossop M, Stewart D, Browne N, Marsden J (2002) Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses. Addiction 97:1259\u20131267","journal-title":"Addiction"},{"key":"4308_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1037\/a0015575","volume":"97","author":"AG Greenwald","year":"2009","unstructured":"Greenwald AG, Poehlman TA, Uhlmann EL, Banaji MR (2009) Understanding and using the implicit association test: III. Meta-analysis of predictive validity. J Pers Soc Psychol 97:17","journal-title":"J Pers Soc Psychol"},{"key":"4308_CR17","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.psyneuen.2009.01.005","volume":"34","author":"AJ Guastella","year":"2009","unstructured":"Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS (2009) A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 34:917\u2013923","journal-title":"Psychoneuroendocrinology"},{"key":"4308_CR18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","volume":"67","author":"AJ Guastella","year":"2010","unstructured":"Guastella AJ, Einfeld SL, Gray KM, Rinehart NJ, Tonge BJ, Lambert TJ, Hickie IB (2010) Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry 67:692\u2013694","journal-title":"Biol Psychiatry"},{"key":"4308_CR19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/00005053-196906000-00004","volume":"148","author":"CA Haertzen","year":"1969","unstructured":"Haertzen CA, Hooks NT Jr (1969) Changes in personality and subjective experience associated with the chronic adminstration and withdrawal of opiates. J Nerv Ment Dis 148:606\u2013614","journal-title":"J Nerv Ment Dis"},{"key":"4308_CR20","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The fagerstrom test for nicotine. Br J Addict 86:1119\u201327","journal-title":"Br J Addict"},{"key":"4308_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.biopsych.2006.05.030","volume":"61","author":"E Hollander","year":"2007","unstructured":"Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L, Anagnostou E, Wasserman S (2007) Oxytocin increases retention of social cognition in autism. Biol Psychiatry 61:498\u2013503","journal-title":"Biol Psychiatry"},{"key":"4308_CR22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/cpt1972136923","volume":"13","author":"CE Inturrisi","year":"1971","unstructured":"Inturrisi CE, Verebely K (1971) Disposition of methadone in man after a single oral dose. Clin Pharmacol Ther 13:923\u2013930","journal-title":"Clin Pharmacol Ther"},{"key":"4308_CR23","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1469-8986.1992.tb02052.x","volume":"29","author":"JR Jennings","year":"1992","unstructured":"Jennings JR, Kamarck T, Stewart C, Eddy M, Johnson P (1992) Alternate cardiovascular baseline assessment techniques: vanilla or resting baseline. Psychophysiology 29:742\u201350","journal-title":"Psychophysiology"},{"key":"4308_CR24","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/16066350902770458","volume":"17","author":"JF Kelly","year":"2009","unstructured":"Kelly JF, Magill M, Stout RL (2009) How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous. Addict Res Theory 17:236\u2013259","journal-title":"Addict Res Theory"},{"key":"4308_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0899-3289(96)90003-6","volume":"8","author":"DK Knight","year":"1996","unstructured":"Knight DK, Simpson DD (1996) Influences of family and friends on client progress during drug abuse treatment. J Subst Abus 8:417\u2013429","journal-title":"J Subst Abus"},{"key":"4308_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1126\/science.278.5335.52","volume":"278","author":"GF Koob","year":"1997","unstructured":"Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52\u201358","journal-title":"Science"},{"key":"4308_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0165-1781(03)00130-6","volume":"119","author":"C Kornreich","year":"2003","unstructured":"Kornreich C, Foisy M-L, Philippot P, Dan B, Tecco J, No\u00ebl X, Hess U, Pelc I, Verbanck P (2003) Impaired emotional facial expression recognition in alcoholics, opiate dependence subjects, methadone maintained subjects and mixed alcohol-opiate antecedents subjects compared with normal controls. Psychiatry Res 119:251\u2013260","journal-title":"Psychiatry Res"},{"key":"4308_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/0028-3908(85)90026-7","volume":"24","author":"G Kov\u00e1cs","year":"1985","unstructured":"Kov\u00e1cs G, Horv\u00e1th Z, Sarnyai Z, Faludi M, Telegdy G (1985a) Oxytocin and a C-terminal derivative (Z-prolyl-D-leucine) attenuate tolerance to and dependence on morphine and interact with dopaminergic neurotransmission in the mouse brain. Neuropharmacology 24:413\u2013419","journal-title":"Neuropharmacology"},{"key":"4308_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0024-3205(85)90620-4","volume":"37","author":"GL Kov\u00e1cs","year":"1985","unstructured":"Kov\u00e1cs GL, Borthaiser Z, Telegdy G (1985b) Oxytocin reduces intravenous heroin self-administration in heroin-tolerant rats. Life Sci 37:17\u201326","journal-title":"Life Sci"},{"key":"4308_CR30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/0006-8993(85)91336-8","volume":"328","author":"GL Kovacs","year":"1985","unstructured":"Kovacs GL, Vecsernyes M, Laczi F, Faludi M, Telegdy G, Laszlo FA (1985) Acute morphine treatment and morphine tolerance\/dependence alter immunoreactive oxytocin levels in the mouse hippocampus. Brain Res 328:158\u201360","journal-title":"Brain Res"},{"key":"4308_CR31","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0306-4530(98)00064-X","volume":"23","author":"GL Kov\u00e1cs","year":"1998","unstructured":"Kov\u00e1cs GL, Sarnyai Z, Szab\u00f3 G (1998) Oxytocin and addiction: a review. Psychoneuroendocrinology 23:945\u2013962","journal-title":"Psychoneuroendocrinology"},{"key":"4308_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0091-3057(92)90656-Z","volume":"43","author":"M Kriv\u00e1n","year":"1992","unstructured":"Kriv\u00e1n M, Szab\u00f3 G, Sarnyai Z, Kov\u00e1cs GL, Telegdy G (1992) Oxytocin blocks the development of heroin-enkephalin cross-tolerance in mice. Pharmacol Biochem Behav 43:187\u2013192","journal-title":"Pharmacol Biochem Behav"},{"key":"4308_CR33","unstructured":"Lane KA, Banaji MR, Nosek BA, Greenwald AG (2007) Understanding and using the implicit association test: IV. In: Wittenbrink B, Schwarz N (eds) Implicit measures of attitudes. New York, The Guilford Press, pp 59\u2013102"},{"key":"4308_CR34","doi-asserted-by":"crossref","unstructured":"Lee MR, Glassman M, King-Casas B, Kelly DL, Stein EA, Schroeder J, Salmeron BJ (2014) Complexity of oxytocin\u05f3 s effects in a chronic cocaine dependent population. Eur Neuropsychopharmacol 24:1483\u20131491","DOI":"10.1016\/j.euroneuro.2014.06.005"},{"key":"4308_CR35","doi-asserted-by":"crossref","unstructured":"Lindgren KP, Neighbors C, Westgate E, Salemink E (2014) Self-control and implicit drinking identity as predictors of alcohol consumption, problems, and cravings. J Stud Alcohol Drugs 75:290","DOI":"10.15288\/jsad.2014.75.290"},{"key":"4308_CR36","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1073\/pnas.0911998107","volume":"107","author":"Y Liu","year":"2010","unstructured":"Liu Y, Aragona BJ, Young KA, Dietz DM, Kabbaj M, Mazei-Robison M, Nestler EJ, Wang Z (2010) Nucleus accumbens dopamine mediates amphetamine-induced impairment of social bonding in a monogamous rodent species. Proc Natl Acad Sci 107:1217\u20131222","journal-title":"Proc Natl Acad Sci"},{"key":"4308_CR37","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.psyneuen.2011.02.015","volume":"36","author":"E Macdonald","year":"2011","unstructured":"Macdonald E, Dadds MR, Brennan JL, Williams K, Levy F, Cauchi AJ (2011) A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology 36:1114\u20131126","journal-title":"Psychoneuroendocrinology"},{"key":"4308_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0030754","volume":"81","author":"R Marhe","year":"2013","unstructured":"Marhe R, Waters AJ, Van De Wetering BJM, Franken IHA (2013) Implicit and explicit drug-related cognitions during detoxification treatment are associated with drug relapse: an ecological momentary assessment study. J Consult Clin Psychol 81:1","journal-title":"J Consult Clin Psychol"},{"key":"4308_CR39","doi-asserted-by":"crossref","unstructured":"Mcgregor IS, Callaghan PD, Hunt GE (2008) From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long\u2010term adverse consequences of drug use? Br J Pharmacol 154:358\u2013368","DOI":"10.1038\/bjp.2008.132"},{"key":"4308_CR40","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00213-013-3062-4","volume":"228","author":"AL Mcrae-Clark","year":"2013","unstructured":"Mcrae-Clark AL, Baker NL, Moran-Santa Maria M, Brady KT (2013) Effect of oxytocin on craving and stress response in marijuana-dependent individuals: a pilot study. Psychopharmacology 228:623\u2013631","journal-title":"Psychopharmacology"},{"key":"4308_CR41","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn3044","volume":"12","author":"A Meyer-Lindenberg","year":"2011","unstructured":"Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M (2011) Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 12:524\u2013538","journal-title":"Nat Rev Neurosci"},{"key":"4308_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40263-012-0022-1","volume":"27","author":"A Modabbernia","year":"2013","unstructured":"Modabbernia A, Rezaei F, Salehi B, Jafarinia M, Ashrafi M, Tabrizi M, Hosseini SMR, Tajdini M, Ghaleiha A, Akhondzadeh S (2013) Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia. CNS Drugs 27:57\u201365","journal-title":"CNS Drugs"},{"key":"4308_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1037\/0021-843X.96.2.122","volume":"96","author":"PM Monti","year":"1987","unstructured":"Monti PM, Binkoff JA, Abrams DB, Zwick WR, Nirenberg TD, Liepman MR (1987) Reactivity of alcoholics and nonalcoholics to drinking cues. J Abnorm Psychol 96:122","journal-title":"J Abnorm Psychol"},{"key":"4308_CR44","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.3390\/ijerph6123010","volume":"6","author":"SE Mueller","year":"2009","unstructured":"Mueller SE, Degen B, Petitjean S, Wiesbeck GA, Walter M (2009) Gender differences in interpersonal problems of alcohol-dependent patients and healthy controls. Int J Environ Res Public Health 6:3010\u20133022","journal-title":"Int J Environ Res Public Health"},{"key":"4308_CR45","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/j.psyneuen.2013.03.003","volume":"38","author":"ID Neumann","year":"2013","unstructured":"Neumann ID, Maloumby R, Beiderbeck DI, Lukas M, Landgraf R (2013) Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology 38:1985\u20131993","journal-title":"Psychoneuroendocrinology"},{"key":"4308_CR46","unstructured":"NIDA 2012. Mental Health Services Administration (2012) Results from the 2011 national survey on drug use and health: summary of national findings. NSDUH Series H-44, HHS Publication No (SMA), 12\u20134713"},{"key":"4308_CR47","doi-asserted-by":"crossref","unstructured":"Norman GJ, Cacioppo JT, Morris JS, Karelina K, Malarkey WB, Devries AC, Berntson GG (2011) Selective influences of oxytocin on the evaluative processing of social stimuli. J Psychopharmacol 25(10):1313\u20131319","DOI":"10.1177\/0269881110367452"},{"key":"4308_CR48","unstructured":"Pedersen CA, Boccia ML, Kampov-Polevoi A (2011) Methods and formulations for oxytocin treatment of substance use, psychiatric and other disorders. Google Patents"},{"key":"4308_CR49","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1530-0277.2012.01958.x","volume":"37","author":"CA Pedersen","year":"2013","unstructured":"Pedersen CA, Smedley KL, Leserman J, Jarskog LF, Rau SW, Kampov\u2010Polevoi A, Casey RL, Fender T, Garbutt JC (2013) Intranasal oxytocin blocks alcohol withdrawal in human subjects. Alcohol Clin Exp Res 37:484\u2013489","journal-title":"Alcohol Clin Exp Res"},{"key":"4308_CR50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.psyneuen.2015.06.006","volume":"60","author":"S Radke","year":"2015","unstructured":"Radke S, De Bruijn ERA (2015) Does oxytocin affect mind-reading? A replication study. Psychoneuroendocrinology 60:75\u201381","journal-title":"Psychoneuroendocrinology"},{"key":"4308_CR51","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1345\/aph.10421","volume":"36","author":"DW Raisch","year":"2002","unstructured":"Raisch DW, Fye CL, Boardman KD, Sather MR (2002) Opioid dependence treatment, including buprenorphine\/naloxone. Ann Pharmacother 36:312\u2013321","journal-title":"Ann Pharmacother"},{"key":"4308_CR52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1360-0443.2001.9611038.x","volume":"96","author":"TE Robinson","year":"2001","unstructured":"Robinson TE, Berridge KC (2001) Incentive-sensitization and addiction. Addiction 96:103\u2013114","journal-title":"Addiction"},{"key":"4308_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0306-4530(94)90062-0","volume":"19","author":"Z Sarnyai","year":"1994","unstructured":"Sarnyai Z, Kov\u00e1cs GL (1994) Role of oxytocin in the neuroadaptation to drugs of abuse. Psychoneuroendocrinology 19:85\u2013117","journal-title":"Psychoneuroendocrinology"},{"key":"4308_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pbb.2013.11.019","volume":"119","author":"Z Sarnyai","year":"2014","unstructured":"Sarnyai Z, Kov\u00e1cs GL (2014) Oxytocin in learning and addiction: from early discoveries to the present. Pharmacol Biochem Behav 119:3\u20139","journal-title":"Pharmacol Biochem Behav"},{"key":"4308_CR55","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/35016630","volume":"405","author":"G Schulteis","year":"2000","unstructured":"Schulteis G, Ahmed SH, Morse AC, Koob GF, Everitt BJ (2000) Conditioning and opiate withdrawal. Nature 405:1013\u20134","journal-title":"Nature"},{"key":"4308_CR56","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.cortex.2011.08.003","volume":"48","author":"T Shany-Ur","year":"2012","unstructured":"Shany-Ur T, Poorzand P, Grossman SN, Growdon ME, Jang JY, Ketelle RS, Miller BL, Rankin KP (2012) Comprehension of insincere communication in neurodegenerative disease: lies, sarcasm, and theory of mind. Cortex 48:1329\u20131341","journal-title":"Cortex"},{"key":"4308_CR57","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejphar.2007.09.042","volume":"579","author":"J Shi","year":"2008","unstructured":"Shi J, Zhao L-Y, Copersino ML, Fang Y-X, Chen Y, Tian J, Deng Y, Shuai Y, Jin J, Lu L (2008) PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur J Pharmacol 579:160\u2013166","journal-title":"Eur J Pharmacol"},{"key":"4308_CR58","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1017\/S1092852900020903","volume":"12","author":"DJ Stein","year":"2007","unstructured":"Stein DJ, Van Honk J, Ipser J, Solms M, Panksepp J (2007) Opioids: from physical pain to the pain of social isolation. CNS Spectr 12:669\u2013674","journal-title":"CNS Spectr"},{"key":"4308_CR59","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s002130000637","volume":"154","author":"KB Stoller","year":"2001","unstructured":"Stoller KB, Bigelow GE, Walsh SL, Strain EC (2001) Effects of buprenorphine\/naloxone in opioid-dependent humans. Psychopharmacology 154:230\u2013242","journal-title":"Psychopharmacology"},{"key":"4308_CR60","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1038\/srep03440","volume":"3","author":"N Striepens","year":"2013","unstructured":"Striepens N, Kendrick KM, Hanking V, Landgraf R, Wullner U, Maier W, Hurlemann R (2013) Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci Rep 3:3440","journal-title":"Sci Rep"},{"key":"4308_CR61","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cpr.2009.10.006","volume":"30","author":"JC Veilleux","year":"2010","unstructured":"Veilleux JC, Colvin PJ, Anderson J, York C, Heinz AJ (2010) A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev 30:155\u2013166","journal-title":"Clin Psychol Rev"},{"key":"4308_CR62","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.psyneuen.2014.04.024","volume":"47","author":"JD Woolley","year":"2014","unstructured":"Woolley JD, Chuang B, Lam O, Lai W, O\u2019Donovan A, Rankin KP, Mathalon DH, Vinogradov S (2014) Oxytocin administration enhances controlled social cognition in patients with schizophrenia. Psychoneuroendocrinology 47:116\u201325","journal-title":"Psychoneuroendocrinology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4308-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-016-4308-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4308-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4308-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T08:54:13Z","timestamp":1589619253000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-016-4308-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,3]]},"references-count":62,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["4308"],"URL":"https:\/\/doi.org\/10.1007\/s00213-016-4308-8","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,3]]},"assertion":[{"value":"10 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JDW, PAA, CSS, DF, SB, and SV have no conflicts of interest to report. DSC is a full-time employee of Trigemina, Inc. The opinions expressed here do not necessarily reflect the views or positions of Trigemina, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}